Prognostic Factors in Hodgkin Lymphoma

Hodgkin lymphoma (HL) is among the neoplastic diseases that has the best long-term outcome after cytotoxic treatment. Cure rates approach 80–90%; however, 15–20% of patients will be resistant to therapy (primary refractory) or relapse after treatment. Prognostic factors should help to stratify treat...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Cuccaro, Annarosa, Bartolomei, Francesca, Cupelli, Elisa, Galli, Eugenio, Giachelia, Manuela, Hohaus, Stefan
Format: Artigo
Jezik:Inglês
Izdano: Università Cattolica del Sacro Cuore 2014
Teme:
Review Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4103502/
https://ncbi.nlm.nih.gov/pubmed/25045461
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4084/MJHID.2014.053
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items